IRIS - Res&Arch Institutional Research Information System - Research & Archive

IORIO, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.587
EU - Europa 7.201
AS - Asia 2.043
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 9
SA - Sud America 9
Totale 17.883
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.279
IE - Irlanda 1.759
UA - Ucraina 1.688
IT - Italia 900
SE - Svezia 847
HK - Hong Kong 609
SG - Singapore 513
VN - Vietnam 493
FI - Finlandia 485
DE - Germania 453
RU - Federazione Russa 408
CA - Canada 297
GB - Regno Unito 242
CN - Cina 195
TR - Turchia 104
FR - Francia 80
CH - Svizzera 68
PL - Polonia 46
UZ - Uzbekistan 44
AT - Austria 43
CZ - Repubblica Ceca 29
NL - Olanda 29
RO - Romania 28
BE - Belgio 26
LB - Libano 22
GR - Grecia 20
PT - Portogallo 17
JP - Giappone 16
AU - Australia 14
EU - Europa 14
ES - Italia 9
KR - Corea 9
AE - Emirati Arabi Uniti 8
AM - Armenia 7
BG - Bulgaria 7
MX - Messico 7
BR - Brasile 5
NZ - Nuova Zelanda 5
TW - Taiwan 5
ID - Indonesia 3
IL - Israele 3
IQ - Iraq 3
LU - Lussemburgo 3
CO - Colombia 2
ET - Etiopia 2
GH - Ghana 2
GL - Groenlandia 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
IN - India 1
LV - Lettonia 1
MA - Marocco 1
MC - Monaco 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
PH - Filippine 1
SC - Seychelles 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.883
Salva come PNG Salva come JPEG
Città #
Dublin 1.758
Chandler 1.691
San Mateo 1.102
Jacksonville 768
Hong Kong 605
Dong Ket 489
Medford 489
Princeton 486
Wilmington 366
Altamura 362
Andover 345
Singapore 306
Lawrence 283
Perugia 272
Ottawa 263
Ann Arbor 242
Des Moines 135
Saint Petersburg 130
Norwalk 108
Izmir 104
Beijing 86
Shanghai 75
Ashburn 73
Helsinki 62
Boardman 58
Falls Church 55
San Paolo di Civitate 54
Los Angeles 49
Woodbridge 37
Moscow 36
Redwood City 31
Amelia 25
Brussels 25
New York 24
San Diego 23
Dearborn 22
Redmond 21
Bucharest 20
Den Haag 19
Auburn Hills 18
Frankfurt Am Main 18
Chicago 16
Narni 16
Terni 16
Milan 15
Rome 15
Brno 13
Munich 13
Cardiff 12
Lausanne 12
London 11
Warsaw 11
Houston 10
Kiev 10
Hanover 9
Dubai 8
Seoul 8
Tokyo 8
Bethesda 7
Edinburgh 7
Philadelphia 7
Simi Valley 7
Yerevan 7
Amsterdam 6
Lappeenranta 6
Porto 6
Stockholm 6
College Station 5
Hamilton 5
Timisoara 5
Vienna 5
Wilmot 5
Ashton-under-Lyne 4
Braga 4
Dallas 4
Frankfurt am Main 4
Fremont 4
Iowa City 4
Madrid 4
Melbourne 4
Poli 4
Silver Spring 4
Tappahannock 4
Auckland 3
Belfiore 3
Brandon 3
Chioggia 3
Costa Mesa 3
Fairfield 3
Leicester 3
Luxembourg 3
Montreal 3
Padova 3
Paris 3
Phoenix 3
Seyssinet-Pariset 3
Sofia 3
Southwark 3
Swindon 3
Tel Aviv 3
Totale 11.517
Salva come PNG Salva come JPEG
Nome #
Interventions for enhancing medication adherence. 120
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 118
1286 Prospective consecutive cases of venous thromboembolic diseases at the single Venous thromboembolic Unit of Reggio Emilia 117
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 115
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 90
Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen 86
Establishing the prevalence and prevalence at birth of hemophilia in males a meta-analytic approach using national registries 81
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 81
I disordini congeniti ed acquisiti dell’emostasi e della fibrinolisi 79
Le trombofilie acquisite 78
Prothrombin 202120A mutation in Behcet’s disease 75
Thrombophilia and cerebral vein thrombosis 75
Effect of dermatan sulphate on activated partial thromboplastin time determined with different reagents 75
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 75
Serine base exchange enzyme in commercially available porcine lyophilised platelets: different effect of unfractionated and low molecular weight heparins 74
Answering relevant research questions via careful observation of clinical practice: a fresh look at the old way forward. 74
. The role of thrombophilic states in the bleeding tendency of patients with hemophilia 72
APTT evaluation in the presurgery screening: survey of 5000 patients 71
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 70
IMMUNE TOLERANCE INDUCTION (ITI) IN PATIENTS WITH HEMOPHILIA A AND INHIBITORS: THE ITALIAN RETROSPECTIVE-PROSPECTIVE REGISTRY - THE PROFIT STUDY 70
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 70
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 68
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 68
Prolonged antithrombin activity of low-molecular-weight heparins. Clinical implications for the treatment of thromboembolic diseases 68
ANTITHROMBOTIC PROPHYLAXIS IN ELDERLY PATIENTS ATRIAL FIBRILLATION ADMITTED TO INTERNAL MEDICINE WARDS IN ITALY: ADHERENCE TO GUIDELINES 67
A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation 67
L’organizzazione del centro per il monitoraggio della terapia anticoagulante orale 66
Sustained suppression of hepatitics C by pegylated Interferon (PEG-INF) and Ribavirin in hemophilic patients 66
Sindrome da anticorpi fosfolipidi. Descrizione di un caso clinico con trombosi atriale dx e revisione della casistica di Reggio Emilia 66
Il monitoraggio della terapia anticoagulante orale 65
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. 65
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 65
ACP Journal Club. A 9-factor score predicted 2-year risk for bleeding in outpatients with, or at high risk for, atherothrombosis. 65
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 65
Bioequivalence of B-domain deleted and plasma derived FVIII concentrates. 65
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 65
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 64
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulant 63
Genima study: genetic polymorphysms and myocardial infarction among italian young adults 63
Systematic review of randomized controlled trials of prophylactic clotting factor concentrate in hemophilia 63
The association between venous thromboembolism and physical inactivity in everyday life 62
Influenza vaccination in patients on long-term anticoagulant therapy. 62
Haemophilia A and B and other rare bleeding disorders: an Italian retrospective survey on the intracranial haemorrhagic episodes. 62
Acute ketoacidosisin continuous subcutaneous insulin infusion treated Type 1 diabetics impairs the fibrynolytic capacity 61
Low molecular weight heparin for prevention of venous thromboembolism in elective neurosurgery: a metanalysis 60
Heparin reduces venous thromboembolism in neurosurgery but increases the risk of bleeding. (Iorio A, Agnelli G. Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a metanalysis. Arch Intern Med. 2000;160:2327-2332) 60
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 60
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 60
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 60
D-DIMER TO PREDICT THROMBOSIS RECURRENCE AFTER UNPROVOKED VENOUS THROMBOEMBOLISM: EFFECT OF PATIENT- AND D-DIMER-RELATED FACTORS ON RECURRENCE PREDICTION 60
D-DIMER TO PREDICT RECURRENCE AFTER A FIRST EPISODE OF UNPROVOKED VENOUS THROMBOEMBOLISM: COMPARISON OF AGGREGATE AND INDIVIDUAL PATIENT DATA META-ANALYSIS 60
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 60
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 60
Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. 59
Impact of Thrombophilia on Risk of Arterial Ischemic Stroke or Cerebral Sinovenous Thrombosis in Neonates and Children: A Systematic Review and Meta-Analysis of Observational Studies 59
Studio GEMINA: ruolo dei polimorfismi genetici e dell'omocisteinemia nell'infarto del miocardico in giovani-adulti italiani 58
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 58
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B 58
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS 58
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project 58
Risk factors for venous thromboembolism in patients undergoing elective neurosurgery 57
Prevention of venous thromboembolism after major orthhopedic surgery: summing up evidence about old and new antithrombotic agents 57
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY 57
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 57
Transition to a web-based architecture of the Italian hemophilia registry network. 57
Indoleamina 2,3 diossigenasi e tolleranza al fattore VIII in pazienti affetti da emofilia a grave. 57
Fattori prognostici di successo nell ‘Induzione di immunotolleranza (ITI) negli emofilici a con inibitore high-responding (HR). Uno score predittivo dal registro Italiano. 57
A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. 57
Oral Anticoagulants and small intestinal bacterial overgrowth 56
THE HEMOPHILIA REGISTRY OF THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTRES 56
ACP Journal Club. The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care. 56
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus. 56
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 55
Indoleanmine 2,3-Dioxygenase and Peripheral Tolerance to Exogenous Factor XIII: A Multi-Centre Pilot Study 55
D-DIMER TO PREDICT THROMBOSIS RECURRENCE: COMPARISON OF AGGREGATE DATA AND INDIVIDUAL PATIENT DATA META-ANALYSES. 55
Influenza vaccination in patients on long-term anticoagulant therapy 55
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparison with oral anticoagulant 54
Profilassi della trombosi venosa profonda in neurochirurgia 54
Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony) 54
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venuos Thromboembolism (VTE); the Prospective Randomized 'Prolong' Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) 54
Eradicazione del virus C dell'epatite (HCV) dopo terapia combinata con Interferone Pegilato (PEG-INF) e Rivabirina in pazienti emofilici HIV negativi 54
AJP Journal Club: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancer. 54
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 54
AICE. FINAL RESULTS FROM THE ITALIAN ASSOCIATION OF HEMOPHILIA CENTERS (AICE) SURVEY ON THE CAUSES OF DEATH AMONG ITALIAN HEMOPHILIACS. 54
Case Report: Sequestro polmonare in un paziente con emofilia a grave HIV positivo. 54
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B. 54
Defective indoleamine 2,3-dioxygenase induction is associated with inhibitor development in severe hemophilia a patients carrying f8 gene null mutations. 54
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors. 54
Hyperhomcysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease 53
Systematic Review of Randomized Controlled Trials of Prophilactic Clotting Factor Concentrate in Hemophilia 53
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS 53
Gemina study:genetic polymorphysms and myocardial infarction among italian young adults 52
Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients 52
Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopatic deep venous thrombosis. 52
INDOLEAMINA 2,3 DIOSSIGENASI E TOLLERANZA AL FATTORE VIII IN PAZIENTI AFFETTI DA EMOFILIA A GRAVE. 52
Venous thrombotic risk assessment among factor V Leiden carriers undergone a thrombophilic screening by different types of indications 52
Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study 52
Factor V Leiden and G20210A prothrombin allele are not associated with thrombosis in Behcet’s disease 51
Low-molecular-weight-heparin treatment and cancer: pooled analysis of 908 patients treated for three months and review of the literature 51
Objectives and methodology: Guidelines of the ItalianSociety for Haemostasis and Thrombosis (SISET). 51
Totale 6.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.598 14 71 203 12 202 15 214 264 328 107 24 144
2020/20213.491 34 290 94 314 1.180 165 220 8 303 98 247 538
2021/20223.740 51 742 92 140 123 36 64 1.372 34 25 445 616
2022/20235.912 541 887 95 415 472 660 8 302 2.251 10 193 78
2023/20242.084 157 229 108 36 36 14 507 125 211 82 238 341
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 18.588